StonvexLoading…
StonvexStonvexStonvexCore line items from BZH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $773.34M | $363.49M | $2.37B | $1.58B |
Operating Income | $-50.81M | $-31.84M | $36.60M | $11.80M |
Net Income | $-33.50M | $-32.60M | $45.59M | $15.58M |
EPS (Diluted) | $-1.18 | $-1.13 | $1.52 | $0.52 |
Total Assets | $2.76B | $2.64B | $2.61B | $2.71B |
Total Liabilities | $1.59B | $1.44B | $1.36B | $1.50B |
Cash & Equivalents | $120.40M | $124.35M | $218.57M | $90.42M |
Free Cash Flow OCF − CapEx | $-242.15M | $-170.85M | $3.48M | $-239.22M |
Shares Outstanding | 28.33M | 29.51M | 29.76M | 29.73M |